Charles Nenner Research

Charles Nenner Research

April 13, 2015 | Podcast

David Gurwitz is the Managing Director of Charles Nenner
Research, which provides timing recommendations on various markets throughout
the world to Hedge Funds, Mutual Funds, Money Managers, large institutions, et al., with clients in over 60 countries.  Charles Nenner, who is an
MD, worked for Goldman Sachs for 15 years in their “Technical Analysis”
endeavors, now makes his “Cycle” based predictions available to the
public.  Their goal is to benefit the investor by exiting markets expected
to decline in value.  David is an eclectic guy who makes several
predictions here that you will find to be very interesting.  
Note that the views and opinions expressed by Mr. Gurwitz do not
necessarily reflect those of Charley Wright or Partnervest Advisory Services,
The information should not be interpreted
as investment advice or recommendations, and is provided to educate listeners
on Charles Nenner Research services only.

Free Industry News

Subscribe to our free newsletter for updates and news about alternatives investments.

  • This field is for validation purposes and should be left unchanged.


Latest Alternative Investment News
FinTech: Adyen Launches ‘Payout Services’ For Faster Payouts To The Gig And SMB Economies
June 2, 2023     FinTech, News

Adyen, a global financial technology platform, has launched Payout Services, allowing its customers to make instant payouts to their users or partners. By connecting directly to real-time payment rails, Adyen’s…
Digital Assets: Oracle Red Bull Racing Seeks To Digitize Engagement With Fans On The Sui Blockchain

Oracle Red Bull Racing has announced a multi-year partnership with software company Mysten Labs to collaborate on Sui, which will serve as the team’s Official Blockchain partner. Sui, a Layer…
Venture Capital: Bold, L’Oréal’s Venture Capital Fund, Buys A Stake In Exotic Cosmetic Ingredient Maker Debut
June 2, 2023     News, Venture Capital

L’Oréal’s (EPA: OR) corporate venture capital fund, BOLD, has announced a minority investment in Debut, a US biotech company specializing in the discovery, formulation, and manufacture of novel ingredients and…
Artificial Intelligence: In Flight Simulation, An AI Drone Tries To Kill Its Own Handler
June 2, 2023     Artificial Intelligence, News

During a simulated test at a London summit, an AI-controlled drone turned against its human operator, raising significant ethical concerns. Air Force Colonel Tucker “Cinco” Hamilton shared the incident, which…